Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features

Journal of the National Cancer Institute

Volumn 88, Issue 9, 1996, Pages 601-606

  Rocha, Rafael L ^a   Hilsenbeck, Susan G ^a   Jackson, James G ^a   Lee, Adrian V ^a   Figueroa, José A ^a,c   Yee, Douglas ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; RIBONUCLEASE; SOMATOMEDIN BINDING PROTEIN 3;

ANEUPLOIDY; ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; PROGNOSIS;

ANEUPLOIDY; AUTORADIOGRAPHY; BREAST NEOPLASMS; DENSITOMETRY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMOGLOBINS; HUMANS; IMMUNOBLOTTING; IMMUNORADIOMETRIC ASSAY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; RNA, MESSENGER; RNA, NEOPLASM; S PHASE;

EID: 0029980569     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.9.601     Document Type: Article

References (25)

1. Yee D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Treai 1994;32:85-95.
2. Cullen KJ, Allison A, Martire I, Ellis M, Singer C. Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res Treat 1992;22:21-9.
3. Arteaga CL, Osborne CK. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 1989;49:6237-41.
4. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48-53.
5. Flier JS, Usher P, Moses AC. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptormediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 1986;83:664-8.
6. Humbel RE. Insulin-like growth factors I and II. Eur J Biochem 1990;190;445-62.
7. Ullrich A, Gray A, Tarn AW, Yang-Feng T, Tsubokawa M, Collins C, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986;5:2503-12.
8. Nishimoto I. The IGF-II receptor system: a G protein-linked mechanism. Mol Reprod Dev 1993;35:398-406.
9. Clemmons DR. IGF binding proteins: regulation of cellular actions. Growth Regul 1992:2:80-7.
10. De Mellow JS, Baxter RC. Growth hormonedependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988:156:199-204.
11. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB. Bierich JR. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 1989;125:766-72.
12. Yee D, Favoni RE, Lippman ME, Powell DR. Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res Treat 1991;18:3-10.
13. Pekonen F, Nyman T, Ilvesmaki V, Partanen S. Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res 1992;52:5204-7.
14. Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D. Expression of insulinlike growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 1993;52:196-205.
15. Clemmons DR, Camacho-Hubner C, Coronado E, Osborne CK. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 1990;127:2679-86.
16. McGuire SE, Hilsenbeck SG, Figueroa JA, Jackson JG, Yee D. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett 1994;77:25-32.
17. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993; 268:14964-71.
18. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT Jr, et al. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 1994;158:69-78.
19. Pratt SE, Pollak MN. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 1994;198: 292-7.
20. Oh Y, Muller HL, Pham H, Lamson G, Rosenfeld RG. Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IFGBP)-3 in Hs578T human breast cancer cells. Endrocrinology 1992;131:3123-5.
21. Yee D, Sharma J, Hilsenbeck SG. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph nodenegative breast cancer. J Natl Cancer Inst 1994;86:1785-9.
22. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 1988;48:6691-6.
23. Laborda J. 36B4 cDNA used as an estradiolindependent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 1991;19:3998.
24. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology 1992;131:3051-60.
25. Shao ZM, Sheikh MS, Ordonez JV, Feng P, Kute T, Chen JC, et al. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res 1992;52:5100-3.